Table A3.
Incidence of PE in At-Risk Dasatinib-Treated Patients by the Year They Were Reported in the Study
Year of Treatment | No. of Patients at Risk | No. of PE Incidents (%) |
---|---|---|
≤ 1 year | 258 | 20 (8) |
>1 to ≤ 2 years | 209 | 13 (6) |
>2 to ≤ 3 years | 184 | 11 (6) |
>3 to ≤ 4 years | 160 | 14 (9) |
>4 to ≤ 5 years | 141 | 12 (9) |
Abbreviation: PE, pleural effusion.